Comparison of different preparation techniques of dried blood spot quality controls in newborn screening for congenital adrenal hyperplasia.
In newborn screening, samples suspected for congenital adrenal hyperplasia (CAH), a potentially lethal inborn error of steroid biosynthesis, need to be confirmed using liquid chromatography-tandem mass spectrometry. Daily quality controls (QCs) for the 2nd-tier CAH assay are not commercially availab...
Main Authors: | Nóra Grecsó, Anita Zádori, Ákos Baráth, Zsolt Galla, Gábor Rácz, Csaba Bereczki, Péter Monostori |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0252091 |
Similar Items
-
Storage stability of five steroids and in dried blood spots for newborn screening and retrospective diagnosis of congenital adrenal hyperplasia.
by: Nóra Grecsó, et al.
Published: (2020-01-01) -
Congenital Adrenal Hyperplasias Presenting in the Newborn and Young Infant
by: Antonio Balsamo, et al.
Published: (2020-12-01) -
Landscape of Congenital Adrenal Hyperplasia Newborn Screening in the United States
by: Sari Edelman, et al.
Published: (2020-08-01) -
Wisconsin’s Screening Algorithm for the Identification of Newborns with Congenital Adrenal Hyperplasia
by: Eric R. Bialk, et al.
Published: (2019-09-01) -
Newborn screening for congenital adrenal hyperplasia in New York State
by: Melissa Pearce, et al.
Published: (2016-06-01)